Rates of overall mortality and risk of early and late overall mortality according to GVHD condition. (A) Mortality rates were calculated within sequential 90-day intervals for patients without GVHD shown in green, for patients with grades II-IV GVHD without chronic GVHD shown in blue, and for patients with NIH chronic GVHD shown in red. Small symbols represent the actual mortality rates for each 90-day interval. The smoothed rates were plotted as curves for each condition. (B-C) Risk of early and late overall mortality according to GVHD condition. *Number of patients at risk in the condition at any time during the period of analysis. †Hazard ratios were adjusted for disease, risk category, total body irradiation, age of the patient at HCT, donor/recipient sex, donor type, HLA-mismatch, source of stem cells, GVHD prophylaxis, and CMV serologic status.